Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies

NR Raghani, MR Chorawala, M Mahadik, RB Patel… - Medical Oncology, 2024 - Springer
Cancer, characterized by the uncontrolled proliferation of aberrant cells, underscores the
imperative for innovative therapeutic approaches. Immunotherapy has emerged as a pivotal …

[HTML][HTML] Hairy cell leukemia–etiopathogenesis, diagnosis and modern therapeutic approach

K Maćkowiak, M Jankowiak, K Szewczyk-Golec… - Biochemia …, 2024 - hrcak.srce.hr
Hairy cell leukemia (HCL) represents 2% of all leukemia cases, with men aged above 55
years being the most affected. The most common symptoms of this type of leukemia include …

A hajas sejtes leukémia és kezelése

J Demeter - Hematológia–Transzfuziológia, 2023 - akjournals.com
A hajas sejtes leukémia (HSL) típusos klinikai, morfológiai, immunhisztokémiai és genetikai
jellemzőkkel rendelkező splenikus B-sejtes lymphoma. Ezen indolens lymphomában …